The Biologics Manufacturing Centre (BMC) Inc. positions itself as a key player in biomanufacturing by offering end-to-end production services tailored to the needs of emerging biotech companies and established pharmaceutical firms. Its mission is to support partners in the production of innovative biologics while ensuring quality, flexibility, and responsiveness to meet the growing demands of the market.
End-to-End Manufacturing to Reduce Risk and Accelerate Development
One of the BMC’s major strengths lies in its state-of-the-art 58,000-square-foot facility spread over two levels. It provides comprehensive services ranging from phase 2 and 3 clinical trials to commercial-scale manufacturing. This integrated, end-to-end approach offers clients optimal continuity by eliminating time lost in transitions between different service providers. It reduces risk and accelerates time-to-market through seamless, fully integrated processes.
Our Services
The BMC offers a full range of services, including:
- Analytical Services: Method validation, quality control, and stability testing to ensure compliance with regulatory requirements. Its modern equipment guarantees reliable analytics at every stage of production.
- Drug Substance Manufacturing for Clinical and Commercial Scale: Specializing in small to medium volumes, ideal for biotech companies and specialized biopharmaceutical projects.
- Fill & Finish Services: Single-use, closed isolator technology ensuring a sterile environment and minimizing contamination risks, all while meeting the highest GMP standards.
- Secondary Packaging: The BMC’s packaging lines are designed with flexibility in mind, accommodating both small-scale manual runs and large-scale automated operations.
- Consulting Services: The BMC provides comprehensive consulting services designed to support biopharmaceutical companies at every stage of development and commercialization. Its experts work closely with clients to ensure efficient technology transfer, optimized processes, and regulatory compliance, helping you reduce risks, control costs, and accelerate timelines.
Flexibility and Responsiveness
In a fast-paced environment where needs evolve quickly, the BMC provides an agile infrastructure that easily adapts to changing market demands. It offers quick access to production slots and analytical services, helping clients reduce timelines for clinical batch manufacturing and accelerate development programs.
Risk Mitigation for Investors
The BMC helps reduce investment risks through a Quality Management System built for commercial manufacturing and comprehensive, rigorous analytical testing that ensures product compliance. Its high standards and strict processes minimize the risk of non-compliance and maximize project success.
The Ideal Partner for Biotechs and Pharmaceutical Companies
The BMC offers end-to-end GMP and CL2 production services designed to meet the specific needs of emerging biotechs aiming to bring their products to market with agility and flexibility. It also supports large pharmaceutical companies seeking to diversify their portfolios by producing small to medium volumes batches, all while meeting the most stringent quality standards and regulatory requirements.
By partnering with the BMC, clients avoid the risks and costs typically associated with technology transfers, thanks to its ability to manufacture both clinical and commercial batches in-house.
The BMC also provides rapid access to production slots, an advantage that sets it apart from larger CMOs, allowing clients to benefit from flexible and responsive scheduling.
